Status:
COMPLETED
Colonisation of Scalp by Topical Probiotic Micrococcus Luteus Q24
Lead Sponsor:
BLIS Technologies Limited
Conditions:
Microbial Colonization
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the skin quality improvement and colonization efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the scalp from a serum forma...
Detailed Description
This is a randomized double-blind baseline controlled pilot study with no crossover for the assessment of any changes to the microbial make-up of the skin (The local skin microbiome), detection of col...
Eligibility Criteria
Inclusion
- In general, good health, is 18 - 80 years of age.
- Practice good general body and hair hygiene.
Exclusion
- Have a history of autoimmune disease or are immunocompromised (have a weakened immune system).
- Free from any scalp disease, active cut, or open wound
- On hair loss treatment at least 2 months prior to sampling.
- Have used anti-dandruff shampoos on the scalp and hair for at least 1 week prior to the trial.
- On concurrent antibiotic or antifungal therapy or regular antibiotic or antifungal. use within the last 1 week.
- People with allergies or sensitivity to dairy.
Key Trial Info
Start Date :
January 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06166979
Start Date
January 15 2024
End Date
July 31 2024
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Blis Technologies Ltd
Dunedin, Otago, New Zealand, 9012